- 3PBIOVIAN has obtained French CIR certification for its Turku (Finland) and Pamplona (Spain) sites, valid until 2027.
- The certification enables French partners to access R&D tax incentives when working with 3PBIOVIAN on eligible projects.
3PBIOVIAN has obtained French Crédit d’Impôt Recherche (CIR) certification for its production and development sites in Turku, Finland, and Pamplona, Spain. The certification is valid until 2027 and applies to the company’s services supporting research and development programmes.
The CIR certification recognises the eligibility of 3PBIOVIAN’s services for French companies’ R&D activities. This allows partners to benefit from tax incentives when collaborating with the CDMO on qualifying projects, providing an additional framework to support international research collaborations.
The Turku site has received CIR certification for the first time, while the Pamplona site has completed its recertification process, having previously held the designation. With this outcome, both locations now hold fully valid CIR certification.
3PBIOVIAN stated that the milestone reinforces its ability to deliver end-to-end solutions across development and contract manufacturing for recombinant proteins and advanced therapies, supporting both scientific and technological projects.
Commenting on the achievement, the company said the certification reflects its ongoing commitment to high-value R&D services and international collaboration, with the aim of supporting clients’ operational excellence and advancing biotechnological innovation for patients.
